Skip to content

Innospec

US · IOSP #2663 by market cap Listed 1970
75.56 -1.52 -1.97%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Valuation each multiple against its own 5-year range

P/B ratio 1.44 Cheap vs history 7th percentile
5-year average 2.12 · #23 of 59 in Specialty Chemicals
P/E ratio 14.20 Cheap vs history 6th percentile
5-year average -80.99 · forward 14.42 · #7 of 36 in Specialty Chemicals
P/S ratio 1.06 Cheap vs history 6th percentile
5-year average 1.35 · forward 0.99 · #26 of 61 in Specialty Chemicals

Vs. peers Specialty Chemicals

Company Market cap P/E (TTM) P/B Div yield
Innospec (IOSP) 1.86B 13.35 1.36 2.37%
Linde (LIN) 230.84B 33.39 5.86 1.25%
Ecolab (ECL) 82.65B 40.10 7.93 0.99%
Sherwin-Williams (SHW) 82.08B 31.25 20.64 0.94%
Air Products & Chemicals (APD) 66.16B 124.31 4.63 2.43%
PPG Industries (PPG) 25.87B 16.71 3.05 2.45%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★★★ Fair value86.32 Economic moatNarrow UncertaintyLow

Trading 14.2% below Morningstar's fair value estimate.

Fair value

Innospec Inc is assigned a 5-star quantitative star rating, indicating our belief that this share class offers a compelling opportunity for investors. The stock currently trades at a 7% discount to our quantitative fair value estimate of $86.32 per share, which is reinforced by this estimate's low uncertainty rating.

The firm's valuation metrics increase our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 71.3%, which ranks in the top 45% compared with global peers. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are undervalued.

The company's profitability is an additional encouraging factor. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. The firm's sales yield of 96.6%, a core component of profitability, falls in the top 40% compared with peers globally. This company has a robust ability to generate sales without much capital investment, freeing up more capital to be returned to shareholders in the long run. This characteristic further promotes our favorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.

Economic moat

The company's narrow economic moat rating suggests it should be able to maintain robust profitability for a decade or longer before competition erodes its advantage. Its moat is bolstered by its strong financial health, which indicates low near-term bankruptcy risk.

By Quantitative Equity Report

Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.

Innospec discussion 0 comments

Add a comment